| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-525 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
1987-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1140fe5228c2fe6e74684110a15da115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50bf2573d87ec93fd2060f88ec3b2b30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f64e3fdfb5652ebcbb5329be5ed7ae9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f4428975e8c4f7a53f41cd09fd09215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd374167da3f91b0531fb9afb3dc6d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7fd6d3ff6df5c948a0570683d1ec3cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90ce2417115decaceff6584222f523a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad260c19afd2a4635c0ade016fa1281f |
| publicationDate |
1988-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-S63226298-A |
| titleOfInvention |
Novel physiologically active polypeptide |
| abstract |
PURPOSE:To obtain a human TNF protein composed of a specific amino acid sequence and having improved specific activity and stability, extended reaction spectrum and decreased side effects. CONSTITUTION:The objective physiologically active polypeptide is composed of the amino acid sequence of formula. Met may be bonded to the amino terminal of the polypeptide. A host microbial cell is transformed with a recombinant plasmid containing a DNA region coding the physiologically active polypeptide, the transformed host microbial cell is cultured and the objective physiologically active polypeptide is separated from the cultured product. |
| priorityDate |
1987-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |